Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort - Wikidata - awgldk - TriplyDB

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

http://www.wikidata.org/entity/Q35894094

about

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Lessons learned from human HIV vaccine trials.Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1.Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.CXCL13 is a plasma biomarker of germinal center activity.Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1 HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.Approaches to the induction of HIV broadly neutralizing antibodies.Genetic and structural analyses of affinity maturation in the humoral response to HIV-1.B-cell responses to HIV infection.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.Identification and specificity of broadly neutralizing antibodies against HIV Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus.How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.Germinal center enhancement by extended antigen availability.Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response.Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.Determinants of HIV-1 broadly neutralizing antibody induction.An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques Env-Specific Antibodies in Chronic Infection versus in Vaccination.Synthesis of multivalent glycopeptide conjugates that mimic an HIV epitope.

P2860

Q26746070-9BE343F0-9E59-475E-8054-83BCC3A5C170 Q26764925-AD31F8E9-091C-47E5-A998-EFF37D59FAD5 Q28553360-C46E6749-1A93-4962-BCE2-0DC395A8CA8C Q30234577-8CE4077F-E333-4A74-A612-C3A00560EB38 Q30352300-41D01E21-20FA-4125-829E-3A40E516CE9D Q33557844-55386B6C-4566-4C95-8D7D-D07B63B6E3D9 Q33594304-87CB5103-C4BF-4CF8-9230-1F42F26223C5 Q33786447-D1A6795B-2333-47AF-B812-49EF68609CEE Q33830824-D7DF04B3-621E-417E-BF16-3B2FAE5F5097 Q33867299-0656F276-E18A-48A4-A081-1C9D76505F79 Q36194234-97CCF094-750C-4A19-ACF4-32CF5E848970 Q36239578-E044B656-D3D1-44EC-AEF1-A4D05A694C03 Q36263513-CCEE58AC-0F4F-4B06-83C2-BDF9F182DCD3 Q36306344-C04D98FF-8067-4566-9ADC-5FEAF9A9237C Q36684710-F975B0B3-8742-44A2-9C0D-88FA9CE2C7B4 Q36956100-77A85660-D639-432D-84D9-12B052E8D87E Q37059216-2DCEA37A-41AE-4376-A210-8F583E28B94F Q37213491-E9C9B46E-35EE-4165-9F4B-48AE32396ACC Q37293480-767D7A7F-72F0-4F1C-B0D6-6870FD2A15A9 Q37409268-F6DAA348-0352-41EA-900B-DD69C947D216 Q37415418-783FA0AE-13B7-4BBA-B6AD-865894E0B35C Q37584635-CB062E17-19FF-431E-B19F-178EDB33D411 Q37634061-19F2F711-F2B6-42B5-8C97-A443200760A9 Q38936867-752E2167-EC5B-4192-8B76-4C8D5AF8ECCE Q38992744-DC48F47E-81BB-4CFA-99F2-74D4CD7C2338 Q39108710-D03D38E2-BB90-4BAD-BBE7-B99C9F0EA515 Q39108730-414A60A9-7281-44DE-B764-C8819CA34303 Q39108760-14931EC5-19F0-4C39-A6AD-CE3108CBB2A0 Q39108796-4C14B590-0B80-41C9-A625-9377E3B00586 Q39245066-F3F85F79-45CD-426F-9C44-96707D16AF5A Q39250593-FDC8294C-FC75-443E-8B15-62F20310F8C2 Q39454581-E2792207-8FFC-4794-9373-D417C50FE213 Q40043429-17651101-CBEF-4C2C-B58E-C95A172F827C Q40055103-86FF25A0-9331-4A28-B7F6-68517AD9517E Q40134111-8A0F238C-C3A1-47CE-980B-CB4F80A383DC Q40159859-D7C8D947-9D4C-4E5D-A4B3-D4F6CD4F4FA8 Q40476608-EB14152B-1251-4637-B7F6-12002BF054EC Q40748041-4B9C6A2C-E9CF-40C8-83DD-94F4B29B2559 Q41475637-14983B33-8632-4D58-BC91-7A0B46EBC6E6 Q41835711-8FB1A62C-D74D-456E-A3BA-523F78209096

P2860

Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort

http://www.wikidata.org/entity/Q35894094

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@ast

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@en

type

label

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@ast

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@en

prefLabel

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@ast

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@en

P1433

Q35894094-D7564E0F-00C2-4436-8FF2-B2A36B9EAA58

P1476

Q35894094-58CE4080-D015-41CB-B36E-B137C53A84D6

P2093

Q35894094-02BE021B-1931-47A3-8719-BDEEED0C23B1

Q35894094-052B432B-276E-4B3D-82F1-E2E6463AA26F

Q35894094-08E499E3-DE34-4503-B22E-280C783A22C2

Q35894094-442FA8E0-8749-497E-A3AA-B77458164DFD

Q35894094-68180440-C311-4629-A87D-DA35006B6C03

Q35894094-77B768C8-ED2E-491A-B89D-E1DA02014384

Q35894094-9A8ED2B3-0870-4344-B5E8-756BF734CACF

Q35894094-9F46F48E-5333-40C8-ACB4-75EB576DA0A6

Q35894094-A1691B27-CD1E-4FC5-9ADA-B7F387A8FDE0

Q35894094-A78E2D6D-0C61-419E-AC7F-B8FD64CC1935

P2860

Q35894094-03438C67-012B-46A8-A815-FA3140F0A2D5

Q35894094-086FF465-AA12-4C19-9856-551915BB7592

Q35894094-0AAF3318-7944-4B77-9C20-C5B44250CA19

Q35894094-162732E9-F9E9-41A0-8C3C-022EE1E0725F

Q35894094-17AF9CF4-0590-454B-A03E-2C0B0B66842B

Q35894094-1B8B54BB-B5F0-45D1-A1B1-0AEAE6BA33E1

Q35894094-1CB3776D-E583-45C5-A9E5-1A802FE92179

Q35894094-1D368FE8-B9B8-422B-BAB9-8EAFF0CCE00C

Q35894094-1E00D2D2-DFCA-48DC-A9D0-3F7A2A2C1C52

Q35894094-24F6F4E0-2B46-4A9B-A286-127DF4D8736A

P304

Q35894094-458DEBF2-FA3D-4016-A4E6-71DCBBE6E9C7

P31

Q35894094-569ABD18-C6DA-4355-A51C-1616E4FAE635

P356

Q35894094-56DA205D-EDC6-498A-8611-0784A1C27C9D

P433

Q35894094-EA39DA78-EBDA-4507-8EBC-E28F4AD330B6

P478

Q35894094-99CDA7A3-76CD-4A22-9E85-D067E2E86D66

P50

Q35894094-00D471F6-F601-4477-94C2-034696219C99

Q35894094-2E4082C9-ECEC-4423-B65B-1F796DF9FD5B

Q35894094-3CD8F956-8C7B-43EF-8000-9284884F12DE

Q35894094-5B150379-4307-49EB-8576-D97DF3BDBC2B

Q35894094-68BAB570-8263-422D-AD2F-21A6B16FDB61

Q35894094-99052412-CC85-43CF-88E8-90BFFD7DA2BC

Q35894094-9B164CFA-7830-4EC0-82E1-5FD83DB04464

Q35894094-C8DCC2B9-4338-45E3-A4F4-F0F35D15EC4D

Q35894094-FA71D2B6-9B6D-4CD7-91B1-81B2F8D01E21

Q35894094-FBB41FA5-7623-4075-BB37-70FDA74831F7

P577

Q35894094-1E64D436-6E09-49D7-BD8B-C13E4324E2E3

P5875

Q35894094-B9E71E30-22B5-4394-BFB1-D54256028AFE

P698

Q35894094-A80E284C-E697-4B9E-BF70-5FAD5F3E2190

P921

Q35894094-E612CAE7-71FA-4682-9C69-2A5BB74068F2

P932

Q35894094-13ED2976-D24D-4FF4-9273-3F877A9AFD86

P356

JOURNAL.PPAT.1005369

P1433

P1476

Broadly Neutralizing Antibody ...... n HIV Primary Infection Cohort

@en

P2093

Alejandra Ramos

http://www.w3.org/2001/XMLSchema#string

Ben Murrell

http://www.w3.org/2001/XMLSchema#string

Charoan B Bian

http://www.w3.org/2001/XMLSchema#string

Jianming Tang

http://www.w3.org/2001/XMLSchema#string

Jill Gilmour

http://www.w3.org/2001/XMLSchema#string

Lalinda Wickramasinghe

http://www.w3.org/2001/XMLSchema#string

Melissa Simek

http://www.w3.org/2001/XMLSchema#string

Mubiana Inambao

http://www.w3.org/2001/XMLSchema#string

Pham Phung

http://www.w3.org/2001/XMLSchema#string

Sergei L Kosakovsky-Pond

http://www.w3.org/2001/XMLSchema#string

P2860

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

A Blueprint for HIV Vaccine Discovery

Antibody responses to envelope glycoproteins in HIV-1 infection

HIV-1 neutralizing antibodies: understanding nature's pathways

Virological features associated with the development of broadly neutralizing antibodies to HIV-1

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

P304

e1005369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1005369

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Colin Havenar-Daughton

Eduard J Sanders

Pascal Poignard

P577

2016-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290442204

http://www.w3.org/2001/XMLSchema#string

P698

26766578

http://www.w3.org/2001/XMLSchema#string

P921

P932

4713061

http://www.w3.org/2001/XMLSchema#string